Advancing Medicine, Restoring Lives
Enliven Therapeutics is a biotechnology company focusing on the discovery and development of next generation precision oncology therapeutics. We are advancing cancer treatment by improving upon scientific advancements to address cancer’s unmet needs. The Enliven team of industry-leading chemists and biologists—collaborating with top-tier advisors—are committed to our mission: to help patients with cancer to not only live longer, but live better.
Location: United States, Colorado, Boulder
Employees: 11-50
Total raised: $165M
Founded date: 2019
Investors 3
| Date | Name | Website |
| 20.02.2021 | Logos Capi... | logoscapit... |
| 09.12.2020 | 5AM Ventur... | 5amventure... |
| - | OrbiMed | orbimed.co... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 23.02.2023 | - | $165M | - |
Mentions in press and media 9
| Date | Title | Description |
| 14.05.2024 | Enliven Therapeutics Reports First Quarter Financial Results and Provides a Business Update | Announced positive proof of concept data from Phase 1 clinical trial of ELVN-001 in CML, achieving an initial cumulative MMR rate of 44% (7/16) by 12 weeks in response-evaluable patients Strong balance sheet with $321 million in cash, cash ... |
| 19.03.2024 | Enliven Therapeutics Announces $90 Million Private Placement Financing and Provides Pipeline Updates | - |
| 23.02.2023 | Enliven Therapeutics Closes Merger with Imara and Private Placement of $165 Million | - |
| 23.02.2023 | Enliven Therapeutics Closes Merger with Imara and Private Placement of $165 Million | - |
| 09.12.2020 | Boulder-based oncology company Enliven Therapeutics raises $55M Series A | Enliven Therapeutics Inc., a Boulder-based cancer-drug developer, is exiting from stealth operations by announcing that it raised $55 million in its first funding round. The Series A round includes an unspecified investment from the venture... |
| 07.12.2020 | Enliven Therapeutics : Launches With Vision Of Advancing Medicine And Restoring Lives | BOULDER, Colo., Dec. 7, 2020 /PRNewswire/ -- Enliven Therapeutics, a precision oncology company based in Boulder, CO, is announcing its launch from stealth with a bold mission: To help patients with cancer to not only live longer, but live ... |
| 07.12.2020 | Enliven Therapeutics Launches With Vision Of Advancing Medicine And Restoring Lives | |
| - | Meet the 23 biotech startups that are set to take off in the next 12 months, according to top VCs | Tyler Le/Insider This story is available exclusively to Insider subscribers. Become an Insider and start reading now. Insider asked 12 venture capitalists which biotech startups would take off in the next 12 months. Here are the 23 companie... |
| - | Enliven Therapeutics | “We are a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors to help patients with cancer live longer and better.” |